Improving Patient Access to Care and Treatment Act
Summary
Improving Patient Access to Care and Treatment Act This bill increases the number of days—from 14 to 60—within which a practitioner must administer certain narcotic drugs (e.g., buprenorphine) to a patient for maintenance or detoxification treatment (i.e., substance use disorder treatment) after receiving the drugs from a pharmacy.
Bill status
in committee
1 of 4 stages cleared
Introduction
Nov 2021
Committee Review
Floor Vote
President
Introduced Nov 12, 2021
Last action Nov 1, 2022
Floor votes
How they voted
No floor votes recorded yet.
Full legislative history
Actions timeline
Total actions
4
Key actions
0
Committee
3
Nov 1, 2022
House · Referred to committee
Referred to the Subcommittee on Crime, Terrorism, and Homeland Security.
Nov 15, 2021
House · Referred to committee
Referred to the Subcommittee on Health.
Nov 12, 2021
House · Referred to committee
Referred to the Committee on Energy and Commerce, and in addition to the Committee on the Judiciary, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.
Nov 12, 2021
House · Introduced
Introduced in House
1 primary · 6 co-sponsors
Sponsors
Ask Maddy
·
AI policy assistant
Ask Maddy about HR 5950
Scope: US
Hi! I can help you understand HR 5950. What would you like to know?
Try one of these
i
Maddy answers using official bill text and legislative records. Always verify before sharing.
Sources cited inline